Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (6): 601-602.DOI: 10.3969/j.issn.1673-8640.2022.06.019
Previous Articles Next Articles
Received:2021-07-21
Revised:2021-11-06
Online:2022-06-30
Published:2022-07-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.06.019
| 项目 | P管/（mIU/L） | D管/（mIU/L） | 回收率/% |
|---|---|---|---|
| 甲氧氯普胺兴奋试验 | |||
| 0 min | 87.04 | 1 194.60 | 7.29 |
| 30 min | 1 130.73 | 2 988.73 | 37.83 |
| 60 min | 942.26 | 2 693.82 | 34.98 |
| 90 min | 719.97 | 2 514.62 | 28.63 |
| 120 min | 588.86 | 2 399.90 | 24.54 |
| 180 min | 438.84 | 2 245.59 | 19.54 |
| 溴隐亭抑制试验 | |||
| 抑制前 | 131.64 | 1 402.53 | 9.39 |
| 抑制后 | 12.60 | 726.47 | 1.73 |
| 项目 | P管/（mIU/L） | D管/（mIU/L） | 回收率/% |
|---|---|---|---|
| 甲氧氯普胺兴奋试验 | |||
| 0 min | 87.04 | 1 194.60 | 7.29 |
| 30 min | 1 130.73 | 2 988.73 | 37.83 |
| 60 min | 942.26 | 2 693.82 | 34.98 |
| 90 min | 719.97 | 2 514.62 | 28.63 |
| 120 min | 588.86 | 2 399.90 | 24.54 |
| 180 min | 438.84 | 2 245.59 | 19.54 |
| 溴隐亭抑制试验 | |||
| 抑制前 | 131.64 | 1 402.53 | 9.39 |
| 抑制后 | 12.60 | 726.47 | 1.73 |
| [1] | RICHA V, RAHUL G, SARIKA A. Macroprolactin;a frequent cause of misdiagnosed hyperprolactinemia in clinical practice[J]. J Reprod Infertil, 2010, 11(3):161-167. |
| [2] | HATTORI N, NAKAYAMA Y, KITAGAWA K, et al. Anti-prolactin(PRL) autoantibody-binding sites(epitopes) on PRL molecule in macroprolactinemia[J]. J Endocrinol, 2006, 190(2):287-293. |
| [3] | 陈永健, 徐莉. 巨泌乳素在高泌乳素血症及不同分析系统间的检出分析[A]//2012年浙江省医学微生物与免疫学及医学病毒学学术年会暨革兰阴性菌感染论坛论文集[C]. 杭州:浙江省医学会医学微生物与免疫学分会,浙江省医学会医学病毒学分会,浙江省科学技术协会, 2012. |
| [4] | 黄树芬. 聚乙二醇筛查法应用于高泌乳素血症诊断中的临床意义[J]. 广州医药, 2018, 49(2):67-69. |
| [5] | 李妮. 女性高泌乳素血症患者垂体MRI表现的相关研究[D]. 银川: 宁夏医科大学, 2020. |
| [6] | QUINN A M, RUBINAS T C, GARBINCIUS C J, et al. Determination of ultrafilterable prolactin:elimination of macroprolactin interference with a monomeric prolactin-selective sample pretreatment[J]. Arch Pathol Lab Med, 2006, 130(12):1807-1812. |
| [7] | 李波. 高泌乳素血症中巨泌乳素筛查的临床意义研究[J]. 临床医学工程, 2018, 25(4):459-460. |
| [8] | 陈允, 周道祥. 高泌乳素血症诊断中巨泌乳素筛查试验的临床应用[J]. 中国处方药, 2015, 13(6):2-3. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
